Literature DB >> 10379709

Localized scotomata detected with temporal modulation perimetry in central serous chorioretinopathy.

A J Vingrys1, K Pesudovs.   

Abstract

AIM: Flicker deficits have been reported in various maculopathies, including age-related macular degeneration. We test whether flicker losses exist in patients with central serous chorioretinopathy (CSC) and whether the size and flicker frequency of the target is important in detecting such losses.
METHODS: We examined four CSC patients with temporal modulation (flicker perception) perimetry using the Medmont auto-flicker module (Medmont Pty Ltd, Melbourne, Vic. Australia), as well as static perimetry and colour vision. One case was examined using sophisticated laboratory equipment to precisely measure their temporal contrast sensitivity function (temporal CSF or de Lange curve) using larger targets to consider the effect of target frequency and size. Two patients were followed longitudinally and tested after resolution of the maculopathy. We compared our patients with an age-matched control group of 11 people.
RESULTS: Temporal modulation perimetry detected larger and more localized defects in all cases of active CSC compared with static perimetry. There appeared to be size and frequency tuning to the deficit, with greatest loss being found at 16 Hz with small (0.5 degree) targets. The losses resolved in one case where the retina recovered in 4 weeks, but remained to a lesser degree in another case who suffered a 2 year long fluctuating course before the CSC subsided.
CONCLUSIONS: Temporal modulation perimetry detects a loss of flicker sensitivity in patients with CSC. Deeper and more clearly defined scotomata are found with a flickering stimulus compared with a steady state one. The greatest losses of flicker sensitivity are found with 16 Hz modulation and with small targets located directly over the lesion. The duration of the disease may be important for recovery of flicker sensitivity. Temporal modulation perimetry appears to be a valuable tool for the confirmation of functional loss due to CSC.

Entities:  

Mesh:

Year:  1999        PMID: 10379709     DOI: 10.1046/j.1440-1606.1999.00158.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  3 in total

1.  Characteristics of the normative database for the Humphrey matrix perimeter.

Authors:  Andrew John Anderson; Chris A Johnson; Murray Fingeret; John L Keltner; Paul G D Spry; Michael Wall; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-04       Impact factor: 4.799

2.  Measuring visual function in age-related macular degeneration with frequency-doubling (matrix) perimetry.

Authors:  Andrew John Anderson; Chris A Johnson; John S Werner
Journal:  Optom Vis Sci       Date:  2011-07       Impact factor: 1.973

3.  Effect of Intravitreal Injection of Bevacizumab on Acute Central Serous Chorioretinopathy Patients Who Visited Feiz Hospital during 2014-2015 Period.

Authors:  Mohamad Reza Akhlaghi; Cobra Nasrollahi; Seyed Mohamad Namgar; Farzan Kianersi; Ali Reza Dehghani; Reza Arefpour
Journal:  Adv Biomed Res       Date:  2017-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.